HSBC Holdings
FLNA

HSBC Holdings’s Filana Therapeutics FLNA Stock Holding History

HSBC Holdings’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.8K Hold
10,000
– – ﹤0.01% 2860
2025
Q4 		$19.7K Sell
10,000
-105
-1% -$336 ﹤0.01% 2899
2025
Q3 		$29.6K Hold
10,105
– – ﹤0.01% 2667
2025
Q2 		$18.6K Sell
10,105
-4,626
-31% -$8.23K ﹤0.01% 2981
2025
Q1 		$23K Sell
14,731
-31
-0.2% -$78 ﹤0.01% 2961
2024
Q4 		$33.9K Buy
+14,762
New +$259K ﹤0.01% 3029

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

HSBC Holdings's FLNA Position: Q1 2026 in Review

HSBC Holdings held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 10,000 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2860.

HSBC Holdings first reported a position in FLNA in Q4 2024 and has held it in 6 quarters since. The position peaked at $33.9K in Q4 2024. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • HSBC Holdings held 10,000 shares of Filana Therapeutics worth $16.8K as of Q1 2026.
  • HSBC Holdings left its Filana Therapeutics share count unchanged in Q1 2026.
  • Filana Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2860 holding.
  • HSBC Holdings first reported a position in Filana Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • HSBC Holdings's Filana Therapeutics position peaked at $33.9K in Q4 2024.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.